1. Home
  2. DERM vs SFWL Comparison

DERM vs SFWL Comparison

Compare DERM & SFWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DERM
  • SFWL
  • Stock Information
  • Founded
  • DERM 2014
  • SFWL 2001
  • Country
  • DERM United States
  • SFWL China
  • Employees
  • DERM N/A
  • SFWL N/A
  • Industry
  • DERM Biotechnology: Pharmaceutical Preparations
  • SFWL Trucking Freight/Courier Services
  • Sector
  • DERM Health Care
  • SFWL Industrials
  • Exchange
  • DERM Nasdaq
  • SFWL Nasdaq
  • Market Cap
  • DERM 124.4M
  • SFWL 114.7M
  • IPO Year
  • DERM 2021
  • SFWL 2023
  • Fundamental
  • Price
  • DERM $5.12
  • SFWL $1.28
  • Analyst Decision
  • DERM Strong Buy
  • SFWL
  • Analyst Count
  • DERM 3
  • SFWL 0
  • Target Price
  • DERM $9.50
  • SFWL N/A
  • AVG Volume (30 Days)
  • DERM 159.2K
  • SFWL 86.8K
  • Earning Date
  • DERM 11-12-2024
  • SFWL 09-04-2024
  • Dividend Yield
  • DERM N/A
  • SFWL N/A
  • EPS Growth
  • DERM N/A
  • SFWL N/A
  • EPS
  • DERM 0.04
  • SFWL 0.11
  • Revenue
  • DERM $77,681,000.00
  • SFWL $446,281,000.00
  • Revenue This Year
  • DERM N/A
  • SFWL N/A
  • Revenue Next Year
  • DERM $37.38
  • SFWL N/A
  • P/E Ratio
  • DERM N/A
  • SFWL $11.88
  • Revenue Growth
  • DERM 26.38
  • SFWL 14.80
  • 52 Week Low
  • DERM $2.85
  • SFWL $0.81
  • 52 Week High
  • DERM $8.11
  • SFWL $15.94
  • Technical
  • Relative Strength Index (RSI)
  • DERM 40.57
  • SFWL 44.38
  • Support Level
  • DERM $5.00
  • SFWL $1.25
  • Resistance Level
  • DERM $5.82
  • SFWL $1.36
  • Average True Range (ATR)
  • DERM 0.45
  • SFWL 0.11
  • MACD
  • DERM -0.07
  • SFWL -0.01
  • Stochastic Oscillator
  • DERM 8.99
  • SFWL 18.80

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

About SFWL Shengfeng Development Limited

Shengfeng Development Ltd is a holding company. The company offers contract logistics services comprising planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services. The integrated logistics solution services of the company are comprised of three segments: B2B freight transportation; cloud storage; and value-added services.

Share on Social Networks: